Lacrimal Gland (excluding Lymphoma)
Primary Site | Histology | Schema Discriminator: Lacrimal Gland/Lacrimal Sac | Staging Type |
---|---|---|---|
C695 | 8000-8576, 8940-8950, 8980-8981 | 015 | TNM 7 and Summary Stage |
C695 | 8577-8713, 8800-8939, 8951-8979, 8982-9136, 9141-9508, 9520-9582, 9700-9701 | 015 | Summary Stage only |
If you are working with a site/histology that only summary stages and you need to directly code it, please use the SEER Summary Stage 2000 manual
Notes
C695 Lacrimal gland [excluding lacrimal sac, lacrimal duct] **Note 1:** This schema is based on the UICC chapter *Carcinoma of Lacrimal Gland,* pages 301-303. * **Site-Specific Factor 25, Schema Discriminator: Lacrimal Gland/Lacrimal Sac** is used to discriminate between lacrimal gland, staged by TNM, and lacrimal sac, not staged by TNM. Both sites are coded to ICD-O-3 code C695 * TNM is defined; however, there is no stage group **Note 2:** Laterality must be coded for this site. **Note 3:** In addition to directly assigning TNM, Summary Stage 2000 (SS2000) must be captured. If directly assigning SS2000, use the *Lacrimal Gland* chapter on page 266 of the [SS2000 on-line manual](http://seer.cancer.gov/tools/ssm/SSSM2000-122012.pdf#page=266).Main Data Items
Name | Default Value | Used in Derivation | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Clinical T | Yes | NAACCR #940 | None | ||
Clinical N | Yes | NAACCR #950 | None | ||
Clinical M | Yes | NAACCR #960 | None | ||
TNM Clin Stage Group | 88 | Yes | NAACCR #970 | None | |
Pathologic T | Yes | NAACCR #880 | None | ||
Pathologic N | Yes | NAACCR #890 | None | ||
Pathologic M | Yes | NAACCR #900 | None | ||
TNM Path Stage Group | 88 | Yes | NAACCR #910 | None | |
SSF1: Ki-67/MIB-1 Labeling Index (LI): Ophthalmic | 988 | No | NAACCR #2880 | None | None |
SSF2: Nuclear NM23 Staining | 988 | No | NAACCR #2890 | None | None |
SSF4: Perineural Invasion | 999 | No | NAACCR #2910 | CCCR/Canada COC SEER |
None |
SSF5: Carcinoma ex Pleomorphic Adenoma, Invasion Beyond Capsule | 988 | No | NAACCR #2920 | None | None |
SSF6: Adenoid Cystic Carcinoma - Presence of Basaloid Pattern | 999 | No | NAACCR #2930 | CCCR/Canada COC SEER |
None |
SSF7: Mucoepidermoid Carcinoma - Grade | 988 | No | NAACCR #2861 | None | None |
SSF8: Orbital Bone | 999 | No | NAACCR #2862 | CCCR/Canada COC SEER |
None |
SSF25: Schema Discriminator: Lacrimal Gland/Lacrimal Sac | 015 | Yes | NAACCR #2879 | All | None |
Additional Data Items
Name | Default Value | Used in Derivation | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Year of Diagnosis | No | NAACCR #390 | None | ||
Primary Site | Yes | NAACCR #400 | None | ||
Histology | Yes | NAACCR #522 | None | ||
RX Summ Systemic/Surgery Sequence | Yes | NAACCR #1639 | None | ||
RX Summ Surgery/Radiation Sequence | Yes | NAACCR #1380 | None | ||
Regional Nodes Positive | Yes | NAACCR #820 | None |
Initial Context
Outputs
Name | Default Value | Description | NAACCR Item | Metadata |
---|---|---|---|---|
Derived Version | 1.2 | None | None | |
Derived SEER Clin Stage Group | 88 |
NAACCR #3610
None |
None | |
Derived SEER Path Stage Group | 88 |
NAACCR #3605
None |
None | |
Derived SEER Combined Stage Group | 88 |
NAACCR #3614
None |
None | |
Derived SEER Combined T | 88 |
NAACCR #3616
None |
None | |
Derived SEER Combined N | 88 |
NAACCR #3618
None |
None | |
Derived SEER Combined M | 88 |
NAACCR #3620
None |
None | |
Derived SEER Combined T Source | <BLANK> |
NAACCR #3622
None |
None | |
Derived SEER Combined N Source | <BLANK> |
NAACCR #3624
None |
None | |
Derived SEER Combined M Source | <BLANK> |
NAACCR #3626
None |
None |